It's always interesting to learn about the medical advancements which occur outside of the United States. I believe that these possess great potential for the future and I would like to think that they could carry over to other areas of the world as well. This is especially true when it comes to glioblastoma research, or that tied into any kind of brain cancer in general. Bevacizumab may not be the most common name in the world but, in my mind, it is definitely worth learning about.
It's no wonder why this study had focused so much on glioma in the past. For those who don't know, this is seen as the most common growth that is seen within the brain or the spinal cord, difficult to treat by means of surgery. Out of all of the tumors in the world, these make up about 80% of all of them, which goes to show you just how common they are amongst patients. As a result, making sure that treatments are tailored to help them is imperative.
An article that was posted on Medscape reported on glioblastoma research, more specifically the work done thanks to the Japanese Military of Health, Labor, and Welfare and bevacizumab. It seems like malignant cases would be targeted and the usage of chemo, along with radiation, would potentially help patients. You may be interested to know, though, that there have been prior cases as well. This is the kind of news which, in my opinion, is worthy of mention by authorities on the matter, V.A.B.C. included.
Keep in mind that bevacizumab has been approved in the United States but not for new patients. Rather, the article stated that it was utilized in order to assist those with recurrent cases. However, there have been concerns about the method and how it wouldn't be able to help patients. A meeting at the annual American Society of Clinical Oncology stated that there wasn't a clear benefit, though it seems like this is still being focused on, which gives me hope that there is still potential.
My only hope is that findings are far more prevalent because of the news at hand. I know that glioblastoma research is a noble endeavor to go about and the level of work which is seen is, in my eyes, some of the best. However, I think that more facts should be put to use and I think that various therapies can make certain of this. Hopefully the results in question can be put to use so that, in the future, therapies can become much more effective.
It's no wonder why this study had focused so much on glioma in the past. For those who don't know, this is seen as the most common growth that is seen within the brain or the spinal cord, difficult to treat by means of surgery. Out of all of the tumors in the world, these make up about 80% of all of them, which goes to show you just how common they are amongst patients. As a result, making sure that treatments are tailored to help them is imperative.
An article that was posted on Medscape reported on glioblastoma research, more specifically the work done thanks to the Japanese Military of Health, Labor, and Welfare and bevacizumab. It seems like malignant cases would be targeted and the usage of chemo, along with radiation, would potentially help patients. You may be interested to know, though, that there have been prior cases as well. This is the kind of news which, in my opinion, is worthy of mention by authorities on the matter, V.A.B.C. included.
Keep in mind that bevacizumab has been approved in the United States but not for new patients. Rather, the article stated that it was utilized in order to assist those with recurrent cases. However, there have been concerns about the method and how it wouldn't be able to help patients. A meeting at the annual American Society of Clinical Oncology stated that there wasn't a clear benefit, though it seems like this is still being focused on, which gives me hope that there is still potential.
My only hope is that findings are far more prevalent because of the news at hand. I know that glioblastoma research is a noble endeavor to go about and the level of work which is seen is, in my eyes, some of the best. However, I think that more facts should be put to use and I think that various therapies can make certain of this. Hopefully the results in question can be put to use so that, in the future, therapies can become much more effective.
About the Author:
Visit Voices Against Brain Cancer if you are looking for more information about glioblastoma.